C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2004
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/16/2004	US6818772 Dietetics, sleep disorders, eating disorders, sexual disorders, central nervous system disorders, psychological disorders
11/16/2004	US6818767 Neuropeptide y (npy) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818653 6,7-Disubstituted -5,8-quinolinedione derivatives as an antifungal agent
11/16/2004	US6818652 Heterocyclic retinoid compounds
11/16/2004	US6818650 1H-imidazo dimers
11/11/2004	WO2004096773A1 Quinolone derivatives
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096210A1 Acylated indoline and tetrahydroquinoline derivatives as hcv inhibitors
11/11/2004	WO2004072044A3 Urea and thiourea derivatives
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	WO2004056745A3 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
11/11/2004	WO2004052919A3 Peptide deformylase inhibitors
11/11/2004	WO2004017917A3 Method for the prevention and/or treatment of atherosclerosis
11/11/2004	WO2003029220A3 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224982 Crystalline form of aryl aniline beta-2 adrenergic receptor agonist
11/11/2004	US20040224980 Compounds used as drugs in solvents as analgesics
11/11/2004	US20040224969 Salts of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid compounds
11/11/2004	US20040224923 For therapy of bacterial and/or fungal infections
11/11/2004	CA2523336A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	CA2518753A1 Quinolone derivatives
11/10/2004	EP1474403A2 Urea derivatives and their use as vanilloid receptor antagonists
11/10/2004	EP1474401A2 Novel aryl- and heteroarylpiperazines
11/10/2004	EP1474145A1 Quinoline derivatives as npy antagonists
11/10/2004	EP1315702B1 Process to produce halo-4-phenoxyquinolines
11/10/2004	CN1545421A Pharmaceutical compositions of drugs and neutralized acidic polymers
11/04/2004	WO2004095601A2 Organic light emitting devices having reduced pixel shrinkage
11/04/2004	WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	WO2004094385A1 Method for producing ethyl (3r, 5s, 6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-yl]-3,5-dihydroxy-6-heptenoate
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004069792A8 Quinoline-derived amide modulators of vanilloid vr1 receptor
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004	WO2004030629A3 Novel neurokinin antagonists and methods of use thereof
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220237 Asthma and allergic inflammation modulators
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220222 Malonamide derivatives
11/04/2004	US20040220219 Reacting 3-cyanomethylthio-7-fluoro-1-methyl-4-quinolone with an acid
11/04/2004	US20040220218 Chlorinated heterocyclic compounds and methods of synthesis
11/04/2004	US20040220217 Carboxylated heterocyclic compounds and methods of synthesis
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/04/2004	CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004	CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/03/2004	EP1472228A1 Process for the manufacture of hmg-coa reductase inhibitors
11/03/2004	EP1472227A2 Process for the manufacture of organic compounds
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472213A1 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
11/03/2004	EP1471911A1 Novel crystalline forms of gatifloxacin
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	CN1543468A Processes for preparing calcium salt forms of statins
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives
11/03/2004	CN1173970C Tetrahydroquinoline derivatives as glycine antagonists
11/03/2004	CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/02/2004	US6812229 Carbamate derivative and agricultural/horticultural fungicide
11/02/2004	US6812225 Pyschological disorders; antidepressants
10/2004
10/28/2004	WO2004092196A2 Tie-2 modulators and methods of use
10/28/2004	WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	WO2004092138A1 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
10/28/2004	WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091618A1 Polymorphic form of montelukast sodium
10/28/2004	WO2004091613A2 Substituted phenyl acetamides and their use as protease inhibitors
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004091485A2 Aminoquinoline compounds
10/28/2004	WO2004076386A3 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
10/28/2004	WO2004058726A3 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
10/28/2004	WO2004041151A3 Neuroprotective iron chelators and pharmaceutical compositions comprising them
10/28/2004	WO2004028539A3 1h-imidazo dimers
10/28/2004	US20040215018 use as selective estrogen receptor modulators, and use in inhibiting bone loss, cardiovascular disease, and breast and uterine carcinoma
10/28/2004	US20040215016 reducing 7-fluoro-1-methyl-3-methylsulfinyl-4-quinolone by reducing it in a solvent to produce the thiomethyl intermediate, which is stereo-preferred oxidized to the sulfinyl enantiomer using an optically active camphor based reagent, such as (1S)-(+)- or (1R)-(-)- 10-camphorsulfonyl)oxaziridine
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	US20040214038 Phosphorescent bidentate cyclometallating ligands, e.g., Iridium(III)tris[2-(3 -methyl-2-quinolinyl)-'N)phenyl-'C][Ir(3-Mepq)3)](2-(phenyl)-3-methyl-quinoline); efficiency; organic optoelectronic devices, e.g., phototransistors, photovoltaic cells, and photodetectors
10/28/2004	US20040212773 Redox systems; optical switches
10/28/2004	CA2527170A1 Therapeutic compounds
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521619A1 Aminoquinoline compounds
10/28/2004	CA2521294A1 Process for the synthesis of 3-cyano-7-alkoxy-6-nitro-4-quinolines
10/28/2004	CA2520323A1 Tie-2 modulators and methods of use
10/27/2004	EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/27/2004	EP1470110A2 Method for the production of substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acids
10/27/2004	EP1294694B1 Process for the preparation of quinoline derivatives

1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 277